scispace - formally typeset
E

Eugene Braunwald

Researcher at Brigham and Women's Hospital

Publications -  1758
Citations -  278949

Eugene Braunwald is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Myocardial infarction & TIMI. The author has an hindex of 230, co-authored 1711 publications receiving 264576 citations. Previous affiliations of Eugene Braunwald include Boston University & University of California, San Francisco.

Papers
More filters
Journal ArticleDOI

Optimizing thrombolytic therapy of acute myocardial infarction.

Eugene Braunwald
- 01 Oct 1990 - 
TL;DR: Thrombolytic therapy of acute myocardial infarction has now reached the stage at which the clinical value of the technique for many patients has been clearly established and is no longer in dispute, and it is now undergoing clinical application.
Journal ArticleDOI

Prognostic significance of the Karnofsky Performance Status score in patients with acute myocardial infarction: comparison with the left ventricular ejection fraction and the exercise treadmill test performance. The MILIS Study Group.

D Brezinski, +14 more
- 01 May 1991 - 
TL;DR: In patients who presented with acute myocardial infarction, a lower KPS score 3 weeks before the index infarctions was associated with a higher incidence of congestive heart failure, in-hospital cardiac arrest, and mortality during hospitalization, as compared with patients with KPS scores greater than or equal to 8.
Journal ArticleDOI

Studies on digitalis. VI. Reduction of the oxygen debt after exercise with digoxin in cardiac patients without heart failure.

Richard L. Kahler, +4 more
- 01 Mar 1963 - 
TL;DR: It would appear that digitalis administration is beneficial to at least some patients who have cardiac disease and enlarged hearts and some decrease in cardiac reserve without signs or symptoms of heart failure.
Journal ArticleDOI

Left ventriculo-right atrial communication

Eugene Braunwald, +1 more
- 01 Jun 1960 - 
TL;DR: The definitive diagnosis was established by selective angiocardiography with left ventricular injection in three patients and at operation in the fourth and the importance of preoperative recognition of the lesion and the results of surgical treatment in two patients are discussed.
Journal ArticleDOI

Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes

Eugene Braunwald, +7 more
- 01 Apr 1998 - 
TL;DR: Platelet glycoprotein (GP) IIb/IIIa blockade has the potential to advance treatment of acute coronary syndromes, both as a primary pharmacologic approach and an adjunct to interventional treatment strategies as discussed by the authors.